These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3602473)

  • 21. Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor.
    Martin JR; Beinfeld MC; Wang RY
    Brain Res; 1986 Nov; 397(2):253-8. PubMed ID: 2948613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological study on the mixed CCK8/DA meso-nucleus accumbens pathway: evidence for the existence of storage sites containing the two transmitters.
    Studler JM; Reibaud M; Tramu G; Blanc G; Glowinski J; Tassin JP
    Brain Res; 1984 Apr; 298(1):91-7. PubMed ID: 6326949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.
    White FJ; Wang RY
    Brain Res; 1984 May; 300(1):161-6. PubMed ID: 6145498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens.
    Vickroy TW; Bianchi BR
    Neuropeptides; 1989 Jan; 13(1):43-50. PubMed ID: 2466220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons.
    Kelland MD; Zhang J; Chiodo LA; Freeman AS
    Synapse; 1991 Jun; 8(2):137-43. PubMed ID: 1882334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.
    Marshall FH; Barnes S; Hughes J; Woodruff GN; Hunter JC
    J Neurochem; 1991 Mar; 56(3):917-22. PubMed ID: 1993898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The modulatory effect of neurotensin on [3H]dopamine release from rat nucleus accumbens slices is enhanced after chronic desipramine treatment.
    Reyneke L; Russell VA; Taljaard JJ
    Brain Res; 1987 Nov; 425(1):114-9. PubMed ID: 3427414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
    Marshall FH; Barnes S; Pinnock RD; Hughes J
    Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens.
    Boldry RC; Uretsky NJ
    Neuropharmacology; 1988 Jun; 27(6):569-77. PubMed ID: 2901677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.
    Jiang LH; Ashby CR; Kasser RJ; Wang RY
    Brain Res; 1990 Apr; 513(1):156-60. PubMed ID: 2112416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Ladurelle N; Keller G; Roques BP; Daugé V
    Brain Res; 1993 Nov; 628(1-2):254-62. PubMed ID: 8313154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin-induced release of dopamine in the nucleus accumbens of the spontaneously hypertensive rat.
    Kirouac GJ; Ganguly PK
    Brain Res; 1995 Aug; 689(2):245-53. PubMed ID: 7583328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apomorphine decreases stimulated dopamine release in rat nucleus accumbens but not in neostriatum: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Eur J Pharmacol; 1987 Jul; 139(3):363-4. PubMed ID: 3666014
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices.
    Nurse B; Russell VA; Taljaard JJ
    Neurochem Res; 1988 May; 13(5):403-7. PubMed ID: 3165497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites.
    Léna I; Roques BP; Durieux C
    J Neurochem; 1997 Jan; 68(1):162-8. PubMed ID: 8978722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Neuropharmacology; 1998; 37(2):265-72. PubMed ID: 9680252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased dopamine D2 receptor-mediated inhibition of [14C]acetylcholine release in the dorsomedial part of the nucleus accumbens.
    Russell VA; Allin R; Lamm MC; Taljaard JJ
    Neurochem Res; 1989 Sep; 14(9):877-81. PubMed ID: 2531849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.